1. Germeys, Christine, Vandoorne, Tijs, Davie, Kristofer, De Bock, Katrien, Van Den Bosch, Ludo. 2024. Targeting EGLN2/PHD1 protects motor neurons and normalizes the astrocytic interferon response. In Cell reports, 43, 114719. doi:10.1016/j.celrep.2024.114719. https://pubmed.ncbi.nlm.nih.gov/39255062/
2. Lin, Qisheng, Li, Shu, Jiang, Na, Lu, Renhua, Ni, Zhaohui. 2020. Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy. In Autophagy, 17, 2975-2990. doi:10.1080/15548627.2020.1848971. https://pubmed.ncbi.nlm.nih.gov/33345685/
3. Liu, Xijuan, Wang, Jun, Boyer, Joshua A, Baldwin, Albert S, Zhang, Qing. 2022. Histone H3 proline 16 hydroxylation regulates mammalian gene expression. In Nature genetics, 54, 1721-1735. doi:10.1038/s41588-022-01212-x. https://pubmed.ncbi.nlm.nih.gov/36347944/
4. Zhang, Jing, Wang, Chengyang, Chen, Xi, Liu, Xiaole Shirley, Zhang, Qing. 2015. EglN2 associates with the NRF1-PGC1α complex and controls mitochondrial function in breast cancer. In The EMBO journal, 34, 2953-70. doi:10.15252/embj.201591437. https://pubmed.ncbi.nlm.nih.gov/26492917/
5. Ding, Yipeng, Niu, Huan, Yang, Hua, Xu, Junxue, Jin, Tianbo. 2015. EGLN2 and RNF150 genetic variants are associated with chronic obstructive pulmonary disease risk in the Chinese population. In International journal of chronic obstructive pulmonary disease, 10, 145-51. doi:10.2147/COPD.S73031. https://pubmed.ncbi.nlm.nih.gov/25609945/
智鼠故事 
